OpenVSafe by OpenVAERS
Search V-safe

BC2-29443-75575

3 vaccinations 5 coded responses 29 check-ins 1 free-text entry 0 call cases
Sex
Male
Age at first dose
0-4
ZIP prefix
021 / MA
Registered
2022-10-18
Relationship
Child or adolescent in my care
Guardian
UHU-31331-04086
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-10-17
    Dose 1 — Pfizer-BioNTech
    Co-administered: Flu:Hepatitis B:Hib:Pneumonia:Polio:Rotavirus:Tetanus
  2. 2022-10-18
    Registered in v-safe
  3. 2022-10-18
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · Irritability/crying
    Under 3 check-in
  4. 2022-10-19
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  5. 2022-10-20
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  6. 2022-10-21
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  7. 2022-10-22
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  8. 2022-10-23
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  9. 2022-10-24
    Health check-in — day 7, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  10. 2022-10-31
    Health check-in — day 14, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  11. 2022-11-07
    Health check-in — day 21, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  12. 2022-11-14
    Health check-in — day 28, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  13. 2022-11-21
    Survey response — day 35, dose 1, under 3
    MedDRA: Cough, Respiratory tract congestion — Feeling: Good
    Free text: Cough, congestion
    MedDRA releases: 2024-11 · check-in free text available
  14. 2022-11-28
    Health check-in — day 42, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  15. 2022-12-03
    Dose 2 — Pfizer-BioNTech
  16. 2022-12-21
    Health check-in — day 14, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  17. 2022-12-24
    Health check-in — day 21, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  18. 2022-12-31
    Health check-in — day 28, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  19. 2023-01-07
    Health check-in — day 35, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  20. 2023-01-14
    Health check-in — day 42, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  21. 2023-02-02
    Dose 3 — Pfizer-BioNTech
  22. 2023-02-03
    Health check-in — days 1–6 daily, dose 3, under 3
    Feeling: Fair · Fever · Irritability/crying · Be unable to work or attend school
    Under 3 check-in
  23. 2023-02-04
    Health check-in — days 1–6 daily, dose 3, under 3
    Feeling: Fair · Fever · Irritability/crying, Loss of appetite · Be unable to work or attend school
    Under 3 check-in
  24. 2023-02-05
    Health check-in — days 1–6 daily, dose 3, under 3
    Feeling: Good · None
    Under 3 check-in
  25. 2023-02-06
    Health check-in — days 1–6 daily, dose 3, under 3
    Feeling: Good · None
    Under 3 check-in
  26. 2023-02-07
    Survey response — days 1–6 daily, dose 3, under 3
    MedDRA: Rhinorrhoea — Feeling: Fair · Fever · Irritability/crying · Be unable to work or attend school
    MedDRA releases: 2024-11
  27. 2023-02-09
    Health check-in — day 7, dose 3, under 3
    Feeling: Good · None
    Under 3 check-in
  28. 2023-02-16
    Health check-in — day 14, dose 3, under 3
    Feeling: Good
    Under 3 check-in
  29. 2023-02-23
    Survey response — day 21, dose 3, under 3
    MedDRA: Cough, Irritability, Respiratory tract congestion, Wheezing — Feeling: Poor · Be unable to work or attend school
    MedDRA releases: 2024-11
  30. 2023-03-02
    Health check-in — day 28, dose 3, under 3
    Feeling: Good
    Under 3 check-in
  31. 2023-03-11
    Health check-in — day 35, dose 3, under 3
    Feeling: Good
    Under 3 check-in
  32. 2023-03-16
    Survey response — day 42, dose 3, under 3
    MedDRA: Pyrexia — Feeling: Good · Be unable to work or attend school
    MedDRA releases: 2024-11
  33. 2023-05-04
    Survey response — 3 months, dose 3, under 3
    MedDRA: COVID-19, Norovirus infection — Feeling: Good · Be unable to work or attend school
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12022-10-17Pfizer-BioNTech Flu:Hepatitis B:Hib:Pneumonia:Polio:Rotavirus:Tetanus
22022-12-03Pfizer-BioNTech No
32023-02-02Pfizer-BioNTech No

Free text

Release 12 (Under 3) — day 35, dose 1, under 3

2022-11-21

Symptoms: Cough, congestion

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDCOVID-19 · · ✓
SDIrritability · · ✓
SDNorovirus infection · · ✓
SDPyrexia · · ✓
SDRespiratory tract congestion · · ✓
SDWheezing · · ✓
SRORhinorrhoea · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…